ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ETX E-therapeutics Plc

9.60
0.425 (4.63%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
E-therapeutics Plc LSE:ETX London Ordinary Share GB00B2823H99 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.425 4.63% 9.60 9.40 9.80 9.40 9.00 9.00 2,228,014 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 475k -8.27M -0.0142 -6.62 54.88M
E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9.18p. Over the last year, E-therapeutics shares have traded in a share price range of 8.00p to 24.00p.

E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £54.88 million. E-therapeutics has a price to earnings ratio (PE ratio) of -6.62.

E-therapeutics Share Discussion Threads

Showing 101 to 119 of 2200 messages
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
27/4/2012
10:36
Nice to see it pushing back up again
beaufort1
26/4/2012
11:19
Patience is required here. Plenty of potential but I'm willing to wait for an entry of around 33p. If I miss the boat there are plenty of alternatives.
plughole
25/4/2012
17:28
Closed at a four-year high today, so quite significant, even with Galvan factor
beaufort1
25/4/2012
15:23
yep, felt right pleased with myself over lunch, now just hoping for a retracement back to circa 37p where previous resistance was, if it doesn't i'm a berk!
thedickster
25/4/2012
15:09
All weird stuff today, but perhaps not surprising if some long term holders heading for the exits on near 50% rise.
beaufort1
25/4/2012
13:13
lol Plughole, im almost tempeted to sell and buy back in, when the dust settles! But that has its risks as sods law says not ALL the action is tipster generated! Hey ho, better a price rise than a fall in any event, atually i heard months and months ago that many people said their "Google" technology justifies the market cap alone and more, so you have all the molecules in Phase blah for free!
thedickster
25/4/2012
11:48
Yikes - price certainly moving. Probably pump and dump as you say.
beaufort1
25/4/2012
11:13
Probably unwise to buy just after Galvan issues a report, but it certainly creates a lot of interest. I prefer to buy a few weeks later when the price settles down.
plughole
25/4/2012
10:43
I see someone has already posted this; doh
dynoport
24/4/2012
15:46
yes but at least the stock is getting a bit of publicity...
beaufort1
24/4/2012
12:22
NURSE, medication please, or a crystal meth brekky! LOL They are a quality outfit, of that there is no doubt, but would prefer to see prices going up on news as opposed to R A M P LOL
thedickster
24/4/2012
12:15
Major pumpty dumpty sitting on a wall! Spam emails being sent out and everything!


"The little-known UK biotech that's got David Cameron excited

Dear Subscriber,

On a brisk February morning earlier this year, the Prime Minister headed to Oxford.

He was on his way to visit a little-known British biotech.

What he discovered left him seriously excited.

You see, this tiny company is a world leader in a revolutionary approach to drug discovery.

David Cameron told the small gathering "Their use of pioneering science has the potential to deliver great results".

Click here for your free report

The "Google" of Pharmaceuticals

Put simply, this company has developed a unique "search engine" that could lead to breakthrough treatments for cancer, depression and hospital superbugs.

What's more, this groundbreaking technology is patent-protected.

In 2012 alone, FOUR of its drugs are entering clinical trials.

A wealth of newsflow is expected over the coming months and years.

Click here for your free report

When the clinical data is released, the results could be huge.

That's because ALL of these drugs have the potential to be a blockbuster if they make it onto the market.

One of the City's best kept secrets

This is not something you can sit back and ignore.

In fact, it's already on the radar screens of a handful of those who "know" this field.

This story could explode quickly...

I urge you to view this research immediately.

Best regards,"

lbo
24/4/2012
10:20
Galvan pushing this one.
beaufort1
24/4/2012
09:20
Up again - well something must be happening! Management doing a tour round the City?
beaufort1
23/4/2012
16:05
Yep i got in late last year, biotech-wise also in Scancell and Synairgen, Medgenics and Tissue Regenix All of which have faired better than the one i have said goodbye to , Val,Summ and Rene! Rene will have it's day though i'm sure, just not for a while yet
thedickster
23/4/2012
14:56
yep i have a sneeking suspicion that there could be more buyers that sellers about today......................................
thedickster
23/4/2012
14:31
Up 15% all of a sudden. Maybe someone bought some shares?!
beaufort1
30/3/2012
14:27
A long-dead thread, but finally some action here...
beaufort1
29/3/2012
16:41
Good to see approval of clinical trials
beaufort1
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older

Your Recent History

Delayed Upgrade Clock